Travere Therapeutics(DE:17R)
€33.000.00 (0.00%)
DE:17R
Travere Therapeutics Revenue
€33.00
At close:0.00 (0.00%)
Travere Therapeutics (17R) Revenue
2 Followers
Travere Therapeutics Revenue
Travere Therapeutics had a revenue of 224.56M in the quarter ending Sep 30, 2026, with 32.42%. This bring the company's revenue in the last twelve months to 651.03M, Increased 10.10%. In the fiscal year ending Dec 31, 2025, Travere Therapeutics had annual revenue of 490.73M with 110.45% growth.
- Revenue (ttm)
- 651.03M
- Revenue Growth
- ―
- P/S Ratio
- 9.16
- Revenue/Employee
- EUR 987,380
- Employees
- 497
- Market Cap
- EUR 4.50B
Revenue Chart
Travere Therapeutics Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 490.73M | 257.55M | 110.45% |
| Dec 31, 2024 | 233.18M | 87.94M | 60.55% |
| Dec 31, 2023 | 145.24M | 35.78M | 32.69% |
| Dec 31, 2022 | 109.46M | -22.38M | -16.97% |
| Dec 31, 2021 | 131.84M | -66.48M | -33.52% |
| Dec 31, 2020 | 198.32M | 22.98M | 13.11% |
| Dec 31, 2019 | 175.34M | 11.09M | 6.75% |
| Dec 31, 2018 | 164.25M | 9.31M | 6.01% |
| Dec 31, 2017 | 154.94M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.